Stay updated with breaking news from Chief Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Heron Therapeutics Second Quarter 2023 Earnings Conference Call.
FDA advisory committee meeting to discuss NurOwn® for Amyotrophic Lateral Sclerosis scheduled for September 27, 2023 BrainStorm's Biologics License Application for NurOwn has a Prescription... -Today at 07:06 am- MarketScreener
Successfully calibrated the pioneering dry stack tailings circuit in July, allowing rapid increase of production capacity of the Greentech Plant. ...
AQN earnings call for the period ending June 30, 2023.
COMPANY NEWS: Leadership additions to fuel the next stage of growth and public company readiness as the company executes a plan towards reaching posit...